JP2021514670A5 - - Google Patents
Info
- Publication number
- JP2021514670A5 JP2021514670A5 JP2020566520A JP2020566520A JP2021514670A5 JP 2021514670 A5 JP2021514670 A5 JP 2021514670A5 JP 2020566520 A JP2020566520 A JP 2020566520A JP 2020566520 A JP2020566520 A JP 2020566520A JP 2021514670 A5 JP2021514670 A5 JP 2021514670A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- antigen
- binding fragment
- amino acid
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023175308A JP2024009914A (ja) | 2018-02-20 | 2023-10-10 | 抗アンジオポエチン２抗体およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862633038P | 2018-02-20 | 2018-02-20 | |
| US62/633,038 | 2018-02-20 | ||
| KR1020190018769A KR102497171B1 (ko) | 2018-02-20 | 2019-02-18 | 항-안지오포이에틴-2(Ang2) 항체 및 그의 용도 |
| KR10-2019-0018769 | 2019-02-18 | ||
| PCT/KR2019/001983 WO2019164219A1 (en) | 2018-02-20 | 2019-02-19 | Anti-angiopoietin-2 antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023175308A Division JP2024009914A (ja) | 2018-02-20 | 2023-10-10 | 抗アンジオポエチン２抗体およびその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021514670A JP2021514670A (ja) | 2021-06-17 |
| JP2021514670A5 true JP2021514670A5 (https=) | 2022-02-28 |
| JPWO2019164219A5 JPWO2019164219A5 (https=) | 2022-02-28 |
| JP7366068B2 JP7366068B2 (ja) | 2023-10-20 |
Family
ID=67775161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566520A Active JP7366068B2 (ja) | 2018-02-20 | 2019-02-19 | 抗アンジオポエチン２抗体およびその使用 |
| JP2023175308A Withdrawn JP2024009914A (ja) | 2018-02-20 | 2023-10-10 | 抗アンジオポエチン２抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023175308A Withdrawn JP2024009914A (ja) | 2018-02-20 | 2023-10-10 | 抗アンジオポエチン２抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11498962B2 (https=) |
| EP (1) | EP3755714A4 (https=) |
| JP (2) | JP7366068B2 (https=) |
| KR (1) | KR102497171B1 (https=) |
| CN (1) | CN111741975B (https=) |
| AU (1) | AU2019224694B2 (https=) |
| CA (1) | CA3091613A1 (https=) |
| MX (1) | MX2020008663A (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102497171B1 (ko) | 2018-02-20 | 2023-02-08 | 기초과학연구원 | 항-안지오포이에틴-2(Ang2) 항체 및 그의 용도 |
| KR20220002143A (ko) * | 2020-06-30 | 2022-01-06 | 삼성전자주식회사 | 항-Ang2 항체를 포함하는 코로나바이러스 감염증을 치료하기 위한 조성물 및 그의 용도 |
| US20230312698A1 (en) * | 2020-08-07 | 2023-10-05 | Nanjing GenScript Biotech Co., Ltd. | Antibodies against human angiopoietin-2 and uses thereof |
| CN116209765B (zh) * | 2020-08-19 | 2025-11-07 | 药物抗体公司 | 经修饰抗体及其制备方法 |
| JP7749696B2 (ja) * | 2021-04-23 | 2025-10-06 | ニオテスバイオ インコーポレイテッド | アンジオポエチン－２に特異的に結合する抗体、またはその断片 |
| KR102459211B1 (ko) * | 2021-04-23 | 2022-10-26 | (주)니오테스바이오 | 안지오포이에틴-2에 특이적으로 결합하는 항체, 또는 이의 단편 |
| KR20250128899A (ko) * | 2024-02-20 | 2025-08-28 | 주식회사 맵틱스 | Tie2 및 VEGF에 특이적으로 결합하는 이중 특이적 항체 및 이의 용도 |
| WO2025186364A1 (en) | 2024-03-06 | 2025-09-12 | Jeansson Marie | Angpt2-targeting antibodies for use in the treatment of fibrotic diseases, particularly kidney disease(s), disorder(s) or injury associated with kidney fibrosis |
| CN121231772B (zh) * | 2025-12-02 | 2026-03-17 | 武汉市金银潭医院(武汉市传染病医院) | 抗体夹心法检测猴痘病毒a29l蛋白的试剂或试剂盒及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7667004B2 (en) * | 2001-04-17 | 2010-02-23 | Abmaxis, Inc. | Humanized antibodies against vascular endothelial growth factor |
| US7658924B2 (en) | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| BRPI0519596B1 (pt) | 2004-12-21 | 2022-01-18 | Astrazeneca Ab | Agente de ligação alvejado, anticorpo monoclonal que se liga a angiopoietina-2, molécula de ácido nucleico, vetor, e, uso do agente de ligação alvejado |
| US8133979B2 (en) * | 2008-12-16 | 2012-03-13 | Hoffmann-La Roche Inc. | Antibodies against human angiopoietin 2 |
| JO3182B1 (ar) | 2009-07-29 | 2018-03-08 | Regeneron Pharma | مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2 |
| US8980268B2 (en) * | 2009-07-29 | 2015-03-17 | Regeneron Pharamceuticals, Inc. | Methods for treating cancer by administering an anti-Ang-2 antibody |
| CA2844306C (en) | 2011-08-19 | 2022-08-16 | Regeneron Pharmaceuticals, Inc. | Anti-tie2 antibodies and uses thereof |
| EP2835380B2 (en) * | 2013-07-29 | 2021-04-07 | Samsung Electronics Co., Ltd | Method of blocking vascular leakage using an anti-Ang2 antibody |
| KR102146845B1 (ko) | 2013-07-30 | 2020-08-21 | 삼성전자주식회사 | 앤지오포이에틴-2에 특이적으로 결합하는 항체 및 그의 용도 |
| KR102196450B1 (ko) | 2013-09-17 | 2020-12-30 | 삼성전자주식회사 | Tie2와 결합을 유도하는 항 Ang2 항체를 포함하는 항암제 |
| US9994632B2 (en) | 2014-05-26 | 2018-06-12 | Samsung Electronics Co., Ltd. | Humanized or affinity-matured anti Ang-2 antibody and uses thereof |
| CA2963606A1 (en) | 2014-11-10 | 2016-05-19 | F.Hoffmann-La Roche Ag | Anti-ang2 antibodies and methods of use |
| KR102497171B1 (ko) | 2018-02-20 | 2023-02-08 | 기초과학연구원 | 항-안지오포이에틴-2(Ang2) 항체 및 그의 용도 |
-
2019
- 2019-02-18 KR KR1020190018769A patent/KR102497171B1/ko active Active
- 2019-02-19 AU AU2019224694A patent/AU2019224694B2/en active Active
- 2019-02-19 MX MX2020008663A patent/MX2020008663A/es unknown
- 2019-02-19 EP EP19757411.4A patent/EP3755714A4/en active Pending
- 2019-02-19 CA CA3091613A patent/CA3091613A1/en active Pending
- 2019-02-19 CN CN201980014282.1A patent/CN111741975B/zh active Active
- 2019-02-19 JP JP2020566520A patent/JP7366068B2/ja active Active
-
2020
- 2020-08-17 US US16/995,707 patent/US11498962B2/en active Active
-
2022
- 2022-10-12 US US18/045,964 patent/US12331106B2/en active Active
-
2023
- 2023-10-10 JP JP2023175308A patent/JP2024009914A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514670A5 (https=) | ||
| JP7352973B2 (ja) | 二重特異性抗体及びその使用 | |
| CN109438576B (zh) | 一种抗人cd47单克隆抗体的制备及其应用 | |
| WO2022100613A1 (zh) | 针对密蛋白18a2和cd3的双特异性抗体及其应用 | |
| CN111454359B (zh) | Cd47抗体或其免疫活性片段及应用 | |
| CN114729033B (zh) | 抗α-溶血素的抗体及其应用 | |
| JP2022551836A (ja) | Ｂｃｍａを標的とする抗体、二重特異性抗体及びその用途 | |
| CN106831996B (zh) | 具有cd3e和/或her2靶向功能的双特异性抗体及其用途 | |
| CN108026178B (zh) | 一种C5aR抗体及其制备方法和应用 | |
| CN108997497B (zh) | 特异结合人质膜膜泡关联蛋白pv-1的单克隆抗体及其制备方法与应用 | |
| JP7230819B2 (ja) | 二重特異性抗体 | |
| CN112961250B (zh) | 抗体融合蛋白及其应用 | |
| JP2023513200A (ja) | 抗ｃｄ３および抗ｃｄ１２３二重特異性抗体およびその使用 | |
| WO2020038355A1 (zh) | Tim-3抗体在制备治疗肿瘤的药物中的用途 | |
| WO2018176992A1 (zh) | 新型双特异性抗体及其用途 | |
| US20250059266A1 (en) | Antibodies for treating alpha-synucleinopathies | |
| KR20220167331A (ko) | 항-flt3 항체 및 조성물 | |
| WO2023241656A1 (zh) | 包含抗cldn18.2抗体的双特异性抗体、药物组合物及用途 | |
| CN116368153A (zh) | Zip12抗体 | |
| JPWO2019164219A5 (https=) | ||
| CN110724672A (zh) | 杂交瘤细胞株105d11、抗体及其应用 | |
| CN114805570B (zh) | 一种抗人ace2单克隆抗体及其应用 | |
| TW202108631A (zh) | 一種抗ｃｄ４７抗原結合蛋白及其應用 | |
| CN115073593B (zh) | 新型冠状病毒抗体及其用途 | |
| WO2022127066A9 (zh) | 一种特异性中和辅助性T细胞TGF-β信号的双特异性抗体、其药物组合及其用途 |